HAVCR1 and acute kidney injury: Treatment with anti-Tim-1 agents has also been shown to inhibit NF-κB activation and apoptosis, while Tim-1 inhibition plays a crucial role in preventing cisplatin-induced acute kidney injury, asTim-1 is also a key gene in regulating renal inflammation and fibrosis [21,37‒39] .